IP Library Granted Patent US 9,040,546
Granted Patent B2
US 9,040,546 · App. 14/251,345 · Granted May 26, 2015

Method of treating functional somatic syndromes with combination of famciclovir and celecoxib

Inventor: William L. Pridgen (Tuscaloosa, AL)
Assignee: INNOVATIVE MED CONCEPTS, LLC
A61K31/196A61K31/635A61K31/52A61K31/522A61K31/5415A61K31/415A61K45/06A61K31/427
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,040,546
App. No.
14/251,345
Granted
May 26, 2015
Kind
B2
Abstract

The present invention relates to methods of treating fibromyalgia by administering a therapeutically-effective combination-dosage of famciclovir and celecoxib. The invention is also related to methods of treating functional somatic syndromes by administering a therapeutically-effective combination-dosage of famciclovir and celecoxib.

Claims (5)

1. A method to treat a subject susceptible to or afflicted with one or more functional somatic syndrome conditions, the method comprising administering to the subject a co-acting combination of famciclovir and celecoxib therapeutically-effective to treat at least one functional somatic syndrome condition selected from fibromyalgia, chronic fatigue syndrome and irritable bowel syndrome wherein each of famciclovir and celecoxib is administered in a dosage amount co-acting in combination to provide therapeutically-effective treatment of at least one functional somatic syndrome condition.

2. The method of claim 1 , wherein the treatment-subject has fibromyalgia condition and a gastrointestinal disorder arising from HSV-1 gastrointestinal-tract infection.

3. The method of claim 1 , wherein the therapeutically-effective treatment provides an improved adverse event profile.

4. The method of claim 1 , wherein one or more functional somatic syndrome conditions are fibromyalgia and chronic fatigue syndrome, coexistent in the subject.

5. The method of claim 1 , wherein one or more functional somatic syndrome conditions are fibromyalgia and irritable bowel syndrome, coexistent in the subject.

Assignments (4)
CHANGE OF NAME Recorded Jan 16, 2025
From: VIRIOS THERAPEUTICS, INC.
To: DOGWOOD THERAPEUTICS, INC.
Reel/Frame 069934/0756 →
CHANGE OF NAME Recorded Jul 12, 2023
From: INNOVATIVE MED CONCEPTS, LLC
To: VIRIOS THERAPEUTICS, LLC
Reel/Frame 064265/0418 →
ENTITY CONVERSION Recorded Jul 12, 2023
From: VIRIOS THERAPEUTICS, LLC
To: VIRIOS THERAPEUTICS, INC.
Reel/Frame 064593/0381 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2016
From: PRIDGEN, WILLIAM L., MD
To: INNOVATIVE MED CONCEPTS, LLC
Reel/Frame 038125/0765 →
Continuity (3)
Division 13761056 · Feb 6, 2013
Provisional Application 61595507 · Feb 6, 2012
Related Publication 20140221399A1 · Aug 7, 2014